Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions

doi:10.1084/jem.172.2.547

This Article

	Full Text (PDF, 1319K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Seifert, P. S.
	Articles by Bhakdi, S.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Seifert, P. S.
	Articles by Bhakdi, S.


Social Bookmarking

	What's this?

ARTICLES

Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions

PS Seifert, F Hugo, J Tranum-Jensen, U Zahringer, M Muhly and S Bhakdi
Institute of Medical Microbiology, Johannes-Gutenberg University, Mainz, Federal Republic of Germany.

The major characteristics of human atherosclerotic lesions are similar to those of a chronic inflammatory reaction, namely fibrosis, mesenchymal cell proliferation, the presence of resident macrophages, and cell necrosis. Atherosclerosis exhibits in addition the feature of lipid (mainly cholesterol) accumulation. The results of the present report demonstrate that a specific cholesterol-containing lipid particle present in human atherosclerotic lesions activates the complement system to completion. Thus, lipid could represent a stimulatory factor for the inflammatory reaction, whose underlying mechanistic basis may be, at least in part, complement activation. The complement-activating lipid was purified from saline extracts of aortic atherosclerotic lesions by sucrose density gradient centrifugation followed by molecular sieve chromatography on Sepharose 2B. It contained little protein other than albumin, was 100-500 nm in size, exhibited an unesterified to total cholesterol ratio of 0.58 and an unesterified cholesterol to phospholipid ratio of 1.2. The lipid, termed lesion lipid complement (LCA), activated the alternative pathway of complement in a dose-dependent manner. Lesion-extracted low density lipoprotein (LDL) obtained during the purification procedure failed to activate complement. Specific generation of C3a desArg and C5b-9 by LCA indicated C3/C5 convertase formation with activation proceeding to completion. Biochemical and electron microscopic evaluations revealed that much of the C5b-9 present in atherosclerotic lesions is membraneous, rather than fluid phase SC5b-9. The observations reported herein establish a link between lipid insudation and inflammation in atherosclerotic lesions via the mechanism of complement activation.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Leung, V. W.Y., Yun, S., Botto, M., Mason, J. C., Malik, T. H., Song, W., Paixao-Cavalcante, D., Pickering, M. C., Boyle, J. J., Haskard, D. O. (2009). Decay-Accelerating Factor Suppresses Complement C3 Activation and Retards Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. Am. J. Pathol. 175: 1757-1767 [Abstract] [Full Text]
Matthijsen, R. A., de Winther, M. P.J., Kuipers, D., van der Made, I., Weber, C., Herias, M. V., Gijbels, M. J.J., Buurman, W. A. (2009). Macrophage-Specific Expression of Mannose-Binding Lectin Controls Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. Circulation 119: 2188-2195 [Abstract] [Full Text]
Kinderlerer, A. R., Ali, F., Johns, M., Lidington, E. A., Leung, V., Boyle, J. J., Hamdulay, S. S., Evans, P. C., Haskard, D. O., Mason, J. C. (2008). KLF2-dependent, Shear Stress-induced Expression of CD59: A NOVEL CYTOPROTECTIVE MECHANISM AGAINST COMPLEMENT-MEDIATED INJURY IN THE VASCULATURE. J. Biol. Chem. 283: 14636-14644 [Abstract] [Full Text]
Shagdarsuren, E., Bidzhekov, K., Djalali-Talab, Y., Liehn, E. A., Hristov, M., Matthijsen, R. A., Buurman, W. A., Zernecke, A., Weber, C. (2008). C1-Esterase Inhibitor Protects Against Neointima Formation After Arterial Injury in Atherosclerosis-Prone Mice. Circulation 117: 70-78 [Abstract] [Full Text]
Schepers, A., de Vries, M.R., van Leuven, C.J., Grimbergen, J.M., Holers, V.M., Daha, M.R., van Bockel, J.H., Quax, P.H.A. (2006). Inhibition of Complement Component C3 Reduces Vein Graft Atherosclerosis in Apolipoprotein E3-Leiden Transgenic Mice. Circulation 114: 2831-2838 [Abstract] [Full Text]
Hansson, G. K. (2006). Epidemiology Complements Immunology in the Heart. Arterioscler. Thromb. Vasc. Bio. 26: 2178-2180 [Full Text]
Fosbrink, M., Niculescu, F., Rus, V., Shin, M. L., Rus, H. (2006). C5b-9-induced Endothelial Cell Proliferation and Migration Are Dependent on Akt Inactivation of Forkhead Transcription Factor FOXO1. J. Biol. Chem. 281: 19009-19018 [Abstract] [Full Text]
Ji, S.-R., Wu, Y., Potempa, L. A., Liang, Y.-H., Zhao, J. (2006). Effect of Modified C-Reactive Protein on Complement Activation: A Possible Complement Regulatory Role of Modified or Monomeric C-Reactive Protein in Atherosclerotic Lesions. Arterioscler. Thromb. Vasc. Bio. 26: 935-941 [Abstract] [Full Text]
Speidl, W. S., Exner, M., Amighi, J., Kastl, S. P., Zorn, G., Maurer, G., Wagner, O., Huber, K., Minar, E., Wojta, J., Schillinger, M. (2005). Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis. Eur Heart J 26: 2294-2299 [Abstract] [Full Text]
Sampietro, T, Bigazzi, F, Pino, B D., Rossi, G, Chella, E, Lusso, S, Puntoni, M, Tuoni, M, Bionda, A (2004). Up regulation of C3, C4, and soluble intercellular adhesion molecule-1 co-expresses with high sensitivity C reactive protein in familial hypoalphalipoproteinaemia: further evidence of inflammatory activation. Heart 90: 1438-1442 [Abstract] [Full Text]
Torzewski, M., Suriyaphol, P., Paprotka, K., Spath, L., Ochsenhirt, V., Schmitt, A., Han, S.-R., Husmann, M., Gerl, V. B., Bhakdi, S., Lackner, K. J. (2004). Enzymatic Modification of Low-Density Lipoprotein in the Arterial Wall: A New Role for Plasmin and Matrix Metalloproteinases in Atherogenesis. Arterioscler. Thromb. Vasc. Bio. 24: 2130-2136 [Abstract] [Full Text]
Persson, L., Boren, J., Robertson, A.-K. L., Wallenius, V., Hansson, G. K., Pekna, M. (2004). Lack of Complement Factor C3, but Not Factor B, Increases Hyperlipidemia and Atherosclerosis in Apolipoprotein E-/- Low-Density Lipoprotein Receptor-/- Mice. Arterioscler. Thromb. Vasc. Bio. 24: 1062-1067 [Abstract] [Full Text]
Bhakdi, S., Torzewski, M., Paprotka, K., Schmitt, S., Barsoom, H., Suriyaphol, P., Han, S.-R., Lackner, K. J., Husmann, M. (2004). Possible Protective Role for C-Reactive Protein in Atherogenesis: Complement Activation by Modified Lipoproteins Halts Before Detrimental Terminal Sequence. Circulation 109: 1870-1876 [Abstract] [Full Text]
Oksjoki, R., Jarva, H., Kovanen, P. T., Laine, P., Meri, S., Pentikainen, M. O. (2003). Association Between Complement Factor H and Proteoglycans in Early Human Coronary Atherosclerotic Lesions: Implications for Local Regulation of Complement Activation. Arterioscler. Thromb. Vasc. Bio. 23: 630-636 [Abstract] [Full Text]
Suriyaphol, P., Fenske, D., Zahringer, U., Han, S.-R., Bhakdi, S., Husmann, M. (2002). Enzymatically Modified Nonoxidized Low-Density Lipoprotein Induces Interleukin-8 in Human Endothelial Cells: Role of Free Fatty Acids. Circulation 106: 2581-2587 [Abstract] [Full Text]
Rugonfalvi-Kiss, S., Endresz, V., Madsen, H. O., Burian, K., Duba, J., Prohaszka, Z., Karadi, I., Romics, L., Gonczol, E., Fust, G., Garred, P. (2002). Association of Chlamydia pneumoniae With Coronary Artery Disease and Its Progression Is Dependent on the Modifying Effect of Mannose-Binding Lectin. Circulation 106: 1071-1076 [Abstract] [Full Text]
Hansson, G. K. (2001). Immune Mechanisms in Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 21: 1876-1890 [Abstract] [Full Text]
Lehr, H.-A., Sagban, T. A., Ihling, C., Zahringer, U., Hungerer, K.-D., Blumrich, M., Reifenberg, K., Bhakdi, S. (2001). Immunopathogenesis of Atherosclerosis: Endotoxin Accelerates Atherosclerosis in Rabbits on Hypercholesterolemic Diet. Circulation 104: 914-920 [Abstract] [Full Text]
Kapinsky, M., Torzewski, M., Buchler, C., Duong, C. Q., Rothe, G., Schmitz, G. (2001). Enzymatically Degraded LDL Preferentially Binds to CD14high CD16+ Monocytes and Induces Foam Cell Formation Mediated Only in Part by the Class B Scavenger-Receptor CD36. Arterioscler. Thromb. Vasc. Bio. 21: 1004-1010 [Abstract] [Full Text]
Yasojima, K., Schwab, C., McGeer, E. G., McGeer, P. L. (2001). Generation of C-Reactive Protein and Complement Components in Atherosclerotic Plaques. Am. J. Pathol. 158: 1039-1051 [Abstract] [Full Text]
Torzewski, M., Rist, C., Mortensen, R. F., Zwaka, T. P., Bienek, M., Waltenberger, J., Koenig, W., Schmitz, G., Hombach, V., Torzewski, J. (2000). C-Reactive Protein in the Arterial Intima : Role of C-Reactive Protein Receptor-Dependent Monocyte Recruitment in Atherogenesis. Arterioscler. Thromb. Vasc. Bio. 20: 2094-2099 [Abstract] [Full Text]
Klouche, M., Rose-John, S., Schmiedt, W., Bhakdi, S. (2000). Enzymatically Degraded, Nonoxidized LDL Induces Human Vascular Smooth Muscle Cell Activation, Foam Cell Transformation, and Proliferation. Circulation 101: 1799-1805 [Abstract] [Full Text]
Bhakdi, S., Torzewski, M., Klouche, M., Hemmes, M. (1999). Complement and Atherogenesis : Binding of CRP to Degraded, Nonoxidized LDL Enhances Complement Activation. Arterioscler. Thromb. Vasc. Bio. 19: 2348-2354 [Abstract] [Full Text]
Prohaszka, Z., Duba, J., Lakos, G., Kiss, E., Varga, L., Janoskuti, L., Csaszar, A., Karadi, I., Nagy, K., Singh, M., Romics, L., Fust, G. (1999). Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability. Int Immunol 11: 1363-1370 [Abstract] [Full Text]
Klouche, M., May, A. E., Hemmes, M., Me�ner, M., Kanse, S. M., Preissner, K. T., Bhakdi, S. (1999). Enzymatically Modified, Nonoxidized LDL Induces Selective Adhesion and Transmigration of Monocytes and T-Lymphocytes Through Human Endothelial Cell Monolayers. Arterioscler. Thromb. Vasc. Bio. 19: 784-793 [Abstract] [Full Text]
Schmiedt, W., Kinscherf, R., Deigner, H.-P., Kamencic, H., Nauen, O., Kilo, J., Oelert, H., Metz, J., Bhakdi, S. (1998). Complement C6 Deficiency Protects Against Diet-Induced Atherosclerosis in Rabbits. Arterioscler. Thromb. Vasc. Bio. 18: 1790-1795 [Abstract] [Full Text]
Klouche, M., Gottschling, S., Gerl, V., Hell, W., Husmann, M., Dorweiler, B., Messner, M., Bhakdi, S. (1998). Atherogenic Properties of Enzymatically Degraded LDL : Selective Induction of MCP-1 and Cytotoxic Effects on Human Macrophages. Arterioscler. Thromb. Vasc. Bio. 18: 1376-1385 [Abstract] [Full Text]
Torzewski, J., Torzewski, M., Bowyer, D. E., Frohlich, M., Koenig, W., Waltenberger, J., Fitzsimmons, C., Hombach, V. (1998). C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries. Arterioscler. Thromb. Vasc. Bio. 18: 1386-1392 [Abstract] [Full Text]
Torzewski, M., Klouche, M., Hock, J., Me�ner, M., Dorweiler, B., Torzewski, J., Gabbert, H. E., Bhakdi, S. (1998). Immunohistochemical Demonstration of Enzymatically Modified Human LDL and Its Colocalization With the Terminal Complement Complex in the Early Atherosclerotic Lesion. Arterioscler. Thromb. Vasc. Bio. 18: 369-378 [Abstract] [Full Text]
Torzewski, M., Torzewski, J., Bowyer, D. E., Waltenberger, J., Fitzsimmons, C., Hombach, V., Gabbert, H. E. (1997). Immunohistochemical Colocalization of the Terminal Complex of Human Complement and Smooth Muscle Cell {alpha}-Actin in Early Atherosclerotic Lesions. Arterioscler. Thromb. Vasc. Bio. 17: 2448-2452 [Abstract] [Full Text]
Torzewski, J., Oldroyd, R., Lachmann, P., Fitzsimmons, C., Proudfoot, D., Bowyer, D. (1996). Complement-Induced Release of Monocyte Chemotactic Protein-1 From Human Smooth Muscle Cells : A Possible Initiating Event in Atherosclerotic Lesion Formation. Arterioscler. Thromb. Vasc. Bio. 16: 673-677 [Abstract] [Full Text]
Mason, J. C., Lidington, E. A., Ahmad, S. R., Haskard, D. O. (2002). bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction. Am. J. Physiol. Cell Physiol. 282: C578-C587 [Abstract] [Full Text]